Sakamoto T, Shepherd B S, Madsen S S, Nishioka R S, Siharath K, Richman N H, Bern H A, Grau E G
Hawaii Institute of Marine Biology, University of Hawaii, Kaneohe 96744, USA.
Gen Comp Endocrinol. 1997 Apr;106(1):95-101. doi: 10.1006/gcen.1996.6854.
To date, growth hormone (GH) is known to contribute to seawater adaptation only in salmonid fishes (primitive Euteleostei). Accordingly, the effects of homologous GH and two forms of homologous prolactin (PRL177 and PRL188) on hypoosmoregulatory ability and gill Na+,K(+)-ATPase activity in a more advanced euryhaline cichlid fish, the tilapia (Oreochromis mossambicus), were examined. Following adaptation of hypophysectomized fish to 25% seawater for 3 weeks, fish were given four injections of hormone or vehicle. They were then exposed to 100% seawater for 12 hr and examined for changes in plasma osmolality. Tilapia GH (0.02 and 0.2 microgram/g) significantly improved the ability of tilapia to decrease plasma osmolality following transfer to full-strength seawater, in a dose-related manner. Growth hormone treatment also significantly stimulated gill Na+,K(+)-ATPase activity (0.5 microgram/g). Both tilapia PRLs (PRL177 and PRL188) increased plasma osmolality in 100% seawater and reduced gill Na+,K(+)-ATPase activity, the effects induced by PRL188 being more significant than those by PRL177. Thus, GH may be involved in seawater adaptation of tilapia, a species belonging to the most advanced teleost super-order (Acanthopterygii), whereas both PRLs in tilapia are not involved in seawater adaptation.
迄今为止,已知生长激素(GH)仅在鲑科鱼类(原始真骨鱼类)中有助于海水适应。因此,研究了同源生长激素以及两种同源催乳素(PRL177和PRL188)对一种更高级的广盐性丽鱼科鱼类——罗非鱼(莫桑比克罗非鱼)的低渗调节能力和鳃Na⁺,K⁺-ATP酶活性的影响。将垂体切除的鱼适应25%海水3周后,给鱼注射四次激素或赋形剂。然后将它们暴露于100%海水中12小时,并检测血浆渗透压的变化。罗非鱼生长激素(0.02和0.2微克/克)以剂量相关的方式显著提高了罗非鱼转移到全强度海水后降低血浆渗透压的能力。生长激素处理还显著刺激了鳃Na⁺,K⁺-ATP酶活性(0.5微克/克)。两种罗非鱼催乳素(PRL177和PRL188)都增加了100%海水中的血浆渗透压,并降低了鳃Na⁺,K⁺-ATP酶活性,PRL188诱导的效应比PRL177更显著。因此,生长激素可能参与罗非鱼(属于最先进的硬骨鱼超目(棘鳍总目)的一个物种)的海水适应,而罗非鱼中的两种催乳素均不参与海水适应。